A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy Paller, MD
Northwestern University
Study Chair - David Hansen, MD
University of Utah
Principal Investigator - Joyce Teng, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal London Hospital
London, Whitechapel, United Kingdom
- Stanford University
Palo Alto, California, United States
- Yale University
New Haven, Connecticut, United States
- Park Avenue Dermatology
Orange Park, Florida, United States
- Minnesota Clinical Study Center
Fridley, Minnesota, United States
- Oregon Health and Sciences University
Portland, Oregon, United States
- Dermresearch, Inc.
Austin, Texas, United States
- University of Utah
Murray, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2021
- Primary completion
- 30 Jun 2023
- Completion
- 30 Jun 2023
- Last update posted
- 29 Aug 2024
- Registered enrollment
- 87
- Registry id
- NCT05180708
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.